Cardiovascular Systems Inc (CSII)

The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 340,667 share decrease in total short interest for Cardiovascular Systems, Inc , to 1,623,026, a decrease of 17.35% since 07/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Cardiovascular Systems (CSII) stock advanced today after Leerink upped its rating to 'outperform' as the company has hit a 'fundamental inflection point.'

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), today announced that, following a national search, it has named Scott R.

On Tuesday, August 23, 2016, Cardiovascular Systems' (NASDAQ: CSII) will present at the 5 th Annual InvestMNt Conference sponsored by The CFA Society of Minnesota.

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), today released procedural and 30-day results from its LIBERTY 360° study in a late-breaking presentation at the 2016 Amputation Prevention Symposium (AMP) in Chicago.

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial...

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2016 fourth-quarter conference call on Wednesday, August 3, 2016, at 3:45 p.

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that it has submitted an application to Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for approval of its Diamondback 360 ® Coronary...

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and...

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial...

The most recent short interest data has been released for the 04/15/2016 settlement date, which shows a 320,918 share decrease in total short interest for Cardiovascular Systems, Inc , to 2,813,702, a decrease of 10.24% since 03/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2016 third-quarter conference call on Wednesday, May 4, 2016, at 3:45 p.

Law Offices of Howard G. Smith reminds investors of today's ( April 12, 2016) deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Cardiovascular Systems...

On Wednesday, April 13, 2016, Cardiovascular Systems' (NASDAQ:CSII) Chief Financial Officer, Larry Betterley, will present at the 15 th Annual Needham Healthcare Conference at 10:40 a.

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf...

Trade-Ideas LLC identified Cardiovascular Systems (CSII) as a strong on high relative volume candidate

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) today reported preliminary revenue for its fiscal third quarter ended March 31, 2016.

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased Cardiovascular Systems, Inc.

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Cardiovascular Systems, Inc.

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased Cardiovascular Systems, Inc.

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf...

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Insiders at these companies have been buying shares of their own stock lately.